Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK.
Mark D DaneseEduard SidelnikovGuillermo VillaDavid CatterickMazhar IqbalMichelle GleesonDeborah LubeckJeetesh PatelPublished in: BMJ open (2022)
Despite an increase in high-intensity therapy use and a decline in revascularisation, more than half of patients did not receive high-intensity lipid-lowering therapy by 2017 and incidence rates of MI and IS remained virtually unchanged.
Keyphrases
- high intensity
- risk factors
- cardiovascular disease
- resistance training
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- cross sectional
- fatty acid
- stem cells
- prognostic factors
- adipose tissue
- body composition
- coronary artery disease
- cell therapy
- skeletal muscle
- cardiovascular risk factors